Dean Fanelli

Dr. Dean L. Fanelli is a Special Counsel at Cooley LLP, a global law firm, where he specializes in advising chemical, pharmaceutical, and biotechnology companies on various aspects of intellectual property and patent law.1 With a Ph.D. in Organic Chemistry from Temple University and a J.D. from The George Washington University Law School, Dr. Fanelli brings a unique blend of scientific and legal expertise to his practice.1

Professional Experience

Dr. Fanelli's work at Cooley LLP focuses on:

• Patent portfolio creation and management
• Technology transactions
• Due diligence
• Drafting novelty, freedom-to-operate, and invalidity opinions
• Handling IP issues in mergers and acquisitions
• Hatch-Waxman Act patent litigation
• Biosimilar market and patent assessments1

Prior to joining Cooley, Dr. Fanelli led Seyfarth Shaw's life sciences and chemical IP practice group and was a founding member of Fanelli Haag, an international intellectual property law firm.1

Entrepreneurial Ventures

Beyond his legal practice, Dr. Fanelli has co-founded several biotech companies:

• PhosImmune: A cancer immunotherapy company (acquired by Agenus in 2015)
• C-Reveal Therapeutics: An immuno-oncology company developing small molecule inhibitors
• AexeRNA Therapeutics: An mRNA delivery company working on lipid nanoparticles1

Expertise and Recognition

Dr. Fanelli is recognized for his expertise in:

• Patent prosecution and counseling
• Paragraph IV litigation strategies
• Biosimilar patent identification and strategy
• Inter partes review and interference proceedings
• Patent licensing and IP asset transfers1

He has been acknowledged as a Legal 500 Leading Healthcare Lawyer and an LMG Life Sciences Star.1

Dr. Fanelli frequently speaks at international conferences and webinars on topics related to patent law in the pharmaceutical and biotechnology industries.1 His LinkedIn profile, under the username dean-l-fanelli-ph-d-0377387, reflects his professional background and current position at Cooley LLP.2